EC Number |
Inhibitors |
Structure |
---|
3.1.3.48 | more |
overview, development of inhibitors |
|
3.1.3.48 | more |
overview on recently developed inhibitors |
|
3.1.3.48 | more |
not inhibitory: okadaic acid |
|
3.1.3.48 | more |
not inhibitory: pentamidine, okadaic acid, sodium fluoride up to 5 mM, EDTA up to 10 mM |
|
3.1.3.48 | more |
in absence of externally added Ca2+, no effect of ethylene glycol bis(2-amino-ethylether) N,N,NĀ,NĀ-tetracetic acid or trifluoperazine. Not inhibitory: okadaic acid |
|
3.1.3.48 | more |
inhibition data for isoforms CD45, Cdc25A, VHR; not inhibitory to PTP1B, CD45: disodium 3-(((4-methyl-3-(((2-methyl-5-((3-sulfonatophenyl)carbamoyl)phenyl)carbamoyl)amino)phenyl)carbonyl)amino)benzenesulfonate |
|
3.1.3.48 | more |
enzyme is active in unstimulated or thrombin-stimulated platelets. Enzyme is not active in lysate of platelets adherent to fibrinogen |
|
3.1.3.48 | more |
down-regulation of enzyme activity with small molecule inhibitors suppresses cell spreading and migration to fibronectin, increases Y527 phosphorylation in Src, and decreases phosphorylation of focal adhesion kinase, p130 Crk-associated substrate, and extracellular signal-regulated kinase 1/2 |
|
3.1.3.48 | more |
EDTA, sodium tartrate, sodium fluoride, or okadaic acid have no effect on activity |
|
3.1.3.48 | more |
the presence of the superoxide- and hydrogen peroxide-destroying enzymes superoxide dismutase and catalase has no effect on the rate of the inactivation reaction |
|